By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


VistaGen Therapeutics, Inc. 

384 Oyster Point Boulevard
Suite 8
South San Francisco  California  94080  U.S.A.
Phone: 650-244-9990 Fax: 650-244-9979



Start Up

Company News
VistaGen Therapeutics, Inc. Appoints Mark A. Mcpartland Vice President Of Corporate Development And Investor Relations 10/4/2016 7:27:23 AM
VistaGen Therapeutics, Inc. Provides Business Outlook And Sets Corporate Milestones 9/22/2016 10:41:25 AM
VistaGen Therapeutics, Inc. Appoints Pharmaceutical CNS Drug Development Executive Mark A. Smith M.D., Ph.D. As Chief Medical Officer 6/20/2016 7:27:42 AM
VistaGen Therapeutics, Inc. Completes $10 Million Public Offering 5/16/2016 11:58:31 AM
VistaGen Therapeutics, Inc. Announces Nasdaq Listing And Pricing Of $10.0 Million Public Offering 5/11/2016 6:12:14 AM
VistaGen Therapeutics, Inc. Appoints Jerry Gin, Ph.D., MBA To Its Board Of Directors 3/30/2016 6:22:27 AM
VistaGen Therapeutics, Inc. Bolsters Clinical And Regulatory Advisory Board With Appointments Of Distinguished Key Opinion Leaders In Depression 3/22/2016 6:52:10 AM
VistaGen Therapeutics, Inc. Secures Exclusive Worldwide Commercial Rights To Three Proprietary Stem Cell Technologies From University Health Network 12/23/2015 6:44:20 AM
VistaGen Therapeutics, Inc. Announces First Patient Dosed In NIH-Sponsored Phase 2A Study Of Orally Available AV-101 In Major Depressive Disorder 11/3/2015 6:19:02 AM
Dr. Maurizio Fava, Internationally Renowned Expert In The Field Of Depression, Joins VistaGen Therapeutics, Inc.'s Clinical And Scientific Advisory Board 10/7/2015 7:00:59 AM